Start the conversation
Ambrx Inc. (Nasdaq: AMBX) is the largest IPO this week as it plans to raise $70 million by selling 5.4 million shares at a $12 to $14 range. AMBX is a biotech company that focuses on the treatment of tumors and other diseases. Last year, AMBX reported revenue of $20 million, and the company is expected to have a valuation of $246 million following its IPO. AMBX has not announced an exact date when its shares will begin trading publicly, but the IPO is expected this week.